1227795-46-1

Basic information

• Product Name: 2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-acrylic acid methyl ester
• Synonyms: 2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-acrylic acid methyl ester
• CAS NO: 1227795-46-1
• Molecular Weight: 466.46
• Mol File: 1227795-46-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-acrylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-acrylic acid methyl ester(1227795-46-1)
• EPA Substance Registry System: 2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-acrylic acid methyl ester(1227795-46-1)

Safety Data

• Hazardous Substances Data: 1227795-46-1(Hazardous Substances Data)

Upstream product

• 1227795-42-7 (S)-3-hydroxy-2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-propionic acid methyl ester 
• 1227795-40-5 (S)-3-(tert-butyl-dimethyl-silanyloxy)-2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-propionic acid methyl ester 
• 1227795-38-1 (S)-3-(tert-butyl-dimethyl-silanyloxy)-2-(4-pyridin-2-yl-benzylamino)-propionic acid methyl ester 
• 1227795-36-9 (S)-3-hydroxy-2-(4-pyridin-2-yl-benzylamino)-propionic acid methyl ester 
• 127406-56-8 4-(2'-pyridyl)benzaldehyde 
• 1227795-44-9 (S)-3-chloro-2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-propionic acid methyl ester 

Downstream Products

• 1227795-48-3 rac-2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-3-pyrrolidin-1-yl-propionic acid methyl ester 
• 1227795-51-8 rac-3-imidazol-1-yl-2-{(4-pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-propionic acid methyl ester 

Relevant articles and documents

NOVEL BIS-AMIDES AS ANTI-MALARIAL AGENTS

The invention relates to novel bis-amide derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing one or more of those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria.